The globally synchronized switch from trivalent Oral Polio Vaccine (tOPV) to bivalent Oral Polio Vaccine (bOPV) took place in Nigeria on April 18th 2016. The country is divided into six geopolitical zones. This study reports the experiences and lessons learned from the switch process in the six states that make up Nigeria’s south-south geopolitical zone.
This was a descriptive retrospective review of Nigeria’s switch plan and structures used for implementing the tOPV-bOPV switch in the south-south zone. Nigeria’s National Polio Emergency Operation Centre (NPEOC) protocols, global guidelines and reports from switch supervisors during the switch were used to provide background information for this study. Quantitative data were derived from reviewing switch monitoring and validation documents as submitted to the NPEOC
The switch process took place in all 3078 Health Facilities (HFs) and 123 Local Government Areas (LGAs) that make up the six states in the zone. A total of $139,430 was used for this process. The ‘healthcare personnel’ component received the highest budgetary allocation (59%) followed by the ‘logistics’ component (18%).
Akwa Ibom state was allocated the highest number of healthcare personnel and hence received the most budgetary allocation compared to the six states (total healthcare personnel = 458, total budgetary allocation = $17,428).
Validation of the switch process revealed that eight HFs in Bayelsa, Cross-River, Edo and Rivers states still possessed tOPV in cold-chain while six HFs in Cross-River and Rivers states had tOPV out of cold-chain but without the ‘do not use’ sticker.
Akwa-Ibom was the only state in the zone to have bOPV and Inactivated Polio Vaccine (IPV) available in all its HFs monitored.
The Nigerian tOPV-bOPV switch was successful. For future Oral Polio Vaccine (OPV) withdrawals, implementation of the switch plan would be more feasible with an earlier dissemination of funds from global donor organizations, which would greatly aid timely planning and preparations. Increased budgetary allocation to the ‘logistics’ component to accommodate unexpected hikes in transportation prices and the general inefficiencies with power supply in the country is also advised.
Bassey BE, Vaz RG, Braka F, Komakech W, Maleghemi ST, Akpan GU, et al. Profiling the immunity status of children with non-polio acute flaccid paralysis who had not received any doses of oral polio vaccine in the south–south region, Nigeria 2011–2014. Public Health. 2016;139:148–53. https://doi.org/10.1016/j.puhe.2016.05.009. CrossRefPubMed
Wassilak S, Pate MA, Wannemuehler K, Jenks J, Burns C, Chenoweth P, et al. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis. 2011;203:898–909. https://doi.org/10.1093/infdis/jiq140. CrossRefPubMedPubMedCentral
WHO | Poliomyelitis. WHO. 2017. http://www.who.int/mediacentre/factsheets/fs114/en/. Accessed 9 Jun 2017.
Samangan B, Daykundi NK, Panjsher S-E-P, Uruzgan N, Baghlan H, Bamyan B, et al. Who AFGHANISTAN snapshot as of November 2016. http://applications.emro.who.int/dsaf/AFG/2016/Afg_Polio_snapshot_2016_19270.pdf?ua=1. Accessed 3 Mar 2017.
Polio Global Eradication Initiative. This week – GPEI. http://polioeradication.org/polio-today/polio-now/this-week/. Accessed 5 Jun 2017.
WHO | Oral polio vaccine (OPV). http://www.who.int/biologicals/areas/vaccines/polio/opv/en/. Accessed 3 Aug 2015.
Global Polio eradication Initiative. Global eradication of wild poliovirus type 2 declared – GPEI. 2015. http://polioeradication.org/news-post/global-eradication-of-wild-poliovirus-type-2-declared/. Accessed 3 Mar 2017.
John TJ, Vashishtha VM. Eradicating poliomyelitis: India’s journey from hyperendemic to polio-free status. Indian J Med Res. 2013;137:881–94. http://www.ncbi.nlm.nih.gov/pubmed/23760372. Accessed 3 Mar 2017 PubMedPubMedCentral
Famulare M. Has wild poliovirus been eliminated from Nigeria? PLoS One. 2015;10:e0135765. https://doi.org/10.1371/journal.pone.0135765. CrossRefPubMedPubMedCentral
Mazumdar Tulip. World now 80% polio free, World Health Organization says - BBC news. http://www.bbc.com/news/health-26763385. Accessed 3 Mar 2017.
Hampton LM, Farrell M, Ramirez-Gonzalez A, Menning L, Shendale S, Lewis I, et al. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine — worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:934–8. https://doi.org/10.15585/mmwr.mm6535a3. CrossRefPubMed
Friedrich MJ. Switch from trivalent to bivalent oral polio vaccine. JAMA. 2016;315:2513. https://doi.org/10.1001/jama.2016.6686.
Aylward RB, Hull HF, Cochi SL, Sutter RW, Olive J-M, Melgaard B. Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Heal Organ. 2000;78:285–97.
WHO | Replacing trivalent OPV with bivalent OPV. WHO. 2016. http://www.who.int/immunization/diseases/poliomyelitis/endgame_objective2/en/.
Update on the OPV switch and short term supply constraints for IPV. 2015. http://www.who.int/immunization/diseases/poliomyelitis/endgame_objective2/inactivated_polio_vaccine/Information_Note_on_short_term_supply_constraints_for_IPV-Nov_2015.pdf. Accessed 3 Mar 2017.
Garon J, Seib K, Orenstein WA, Ramirez Gonzalez A, Chang Blanc D, Zaffran M, et al. Polio endgame: the global switch from tOPV to bOPV. Expert Rev Vaccines. 2016;15:693–708. https://doi.org/10.1586/14760584.2016.1140041. CrossRefPubMed
Report of Nigeria’s National Population Commission on the 2006 Census. Popul Dev Rev. 33:206–210. doi: https://doi.org/10.2307/25434601.
WHO | Circulating vaccine-derived poliovirus type 2 – Democratic Republic of the Congo. WHO. 2017. http://www.who.int/csr/don/13-June-2017-polio-drc/en/. Accessed 9 Jul 2017.
EPI polio eradication. The switch from tOPV to bOPV: implementation guild lines. http://www.who.int/immunization/diseases/poliomyelitis/endgame_objective2/oral_polio_vaccine/switch_guidelines-april2015.pdf. Accessed 3 Mar 2017.
- The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016
Bassey Enya Bassey
Rui Gama Vaz
Sylvester Toritseju Maleghemi
Godwin Ubong Akpan
Sisay Gashu Tegegne
Abdul-Aziz Garba Mohammed
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II